Second, the panel of biomarkers that we used studies the innate immune and inflammatory response to viral infection, while CP is supposed to act via antibodies neutralizing SARS-CoV-2 [32] by reducing the quantity of viable virus in infected tissues, in this case the lung parenchyma. Here, CP is linked to viral infectious disease.